Spectrum Pharma (SPPI) Receives FDA Complete Response Letter Related to QAPZOLA NDA
Tweet Send to a Friend
Spectrum Pharma (NASDAQ: SPPI) disclosed the following in a U.S. SEC filing on Friday:Item 8.01 - Other Events.On November 17 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
